Researchers and trial sponsors should consult stakeholders through a transparent and meaningful participatory process which involves them in an early and sustained manner in the design,development,implementation,monitoring and distribution of results of biomedical HIV prevention trials,and participation of individuals should be voluntary and selection of participating communities and individuals must be fair and justified in terms of the scientific goals of the research.
footer
The views expressed herein do not necessarily reflect the official policies of the City and County of San Francisco; nor does mention of the San Francisco Department of Public Health imply its endorsement. Any questions, comments, or suggestions pertaining to this site may be directed to the site administrator by filling out this form.
© Copyright 2024, Department of Public Health, City and County of San Francisco.
